» Articles » PMID: 32336650

Characterization of Early Pregnancy Placental Progesterone Production by Use of Dydrogesterone in Programmed Frozen-thawed Embryo Transfer Cycles

Overview
Publisher Elsevier
Date 2020 Apr 28
PMID 32336650
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

Research Question: When and how does the gradual transition of the endocrine control of early pregnancy from the corpus luteum to the placenta, termed luteoplacental shift, take place?

Design: Prospective analysis of serum progesterone levels in pregnancies (n = 88) resulting from programmed frozen-thawed embryo transfer cycles in which ovulation was suppressed and no corpus luteum was present. Dydrogesterone, which does not cross-react with progesterone in immunoassay or spectrometric assay, was used for luteal phase and early pregnancy support. Progesterone, oestradiol and hCG were measured at regular intervals from before pregnancy achievement until +65 to 71 days after embryo transfer by Roche Elecsys electrochemiluminescence immunoassay (Elecsys ECLIA) and liquid chromatography-tandem mass spectrometry (LC-MS/MS).

Results: Serum progesterone remained at baseline levels on first blood analysis +9 to 15 days after embryo transfer and increased only marginally independently from the type of pregnancy up to +16 to 22 days after embryo transfer. From +23 to 29 days after embryo transfer, progesterone increased non-linearly above 1.0 ng/ml and increased further throughout the first trimester with elevated levels in multiples. Oestradiol levels increased in parallel with progesterone; hCG plateaued around +37 to 43 days. Progesterone levels were significant predictors for pregnancy viability from +23 to 29 days after embryo transfer onwards with best accuracy +37 to 43 days after embryo transfer (receiver operator characteristic analysis area under the curve 0.98; 95% CI 0.94 to 1; P = 0.0009).

Conclusions: The onset of substantial progesterone production is the 7th gestational week. Progesterone increase is non-linear, depends on chorionicity and zygosity, and may have predictive potential on the outcome of pregnancies originating from frozen embryo transfer cycles.

Citing Articles

Successful pregnancy and live birth despite discontinuation of hormone replacement therapy at 3 weeks and 5 days of gestation following vitrified-warmed embryo transfer under a hormone replacement therapy cycle: a case report and literature review.

Katsumata S, Ota K, Takahashi T, Mitsui J, Uchida N, Hiraoka K BMC Pregnancy Childbirth. 2024; 24(1):831.

PMID: 39707226 PMC: 11660545. DOI: 10.1186/s12884-024-07059-w.


The combination of dydrogesterone and micronized vaginal progesterone can render serum progesterone level measurements on the day of embryo transfer and rescue attempts unnecessary in an HRT FET cycle.

Lawrenz B, Kalafat E, Ata B, Del Gallego R, Melado L, Elkhatib I J Assist Reprod Genet. 2024; 41(4):885-892.

PMID: 38372882 PMC: 11052972. DOI: 10.1007/s10815-024-03049-1.


Luteal phase support in assisted reproductive technology.

Garg A, Zielinska A, Yeung A, Abdelmalak R, Chen R, Hossain A Nat Rev Endocrinol. 2023; 20(3):149-167.

PMID: 38110672 DOI: 10.1038/s41574-023-00921-5.


Finding of the optimal preparation and timing of endometrium in frozen-thawed embryo transfer: a literature review of clinical evidence.

Hsueh Y, Huang C, Hung S, Chang C, Hsu H, Yang T Front Endocrinol (Lausanne). 2023; 14:1250847.

PMID: 37711892 PMC: 10497870. DOI: 10.3389/fendo.2023.1250847.


The addition of dydrogesterone improves the outcomes of pregnant women with low progesterone levels when receiving vaginal progesterone alone as luteal support in HRT-FET cycles.

Toriumi R, Horikawa M, Sato C, Shimamura N, Ishii R, Terashima M Reprod Med Biol. 2023; 22(1):e12511.

PMID: 36969958 PMC: 10032329. DOI: 10.1002/rmb2.12511.